XERMELO cpr pell 250 mg 90 pce

7680663740012 CH-66374 A16AX15 07.16.4.
XERMELO cpr pell 250 mg 90 pce
XERMELO cpr pell 250 mg 90 pce
XERMELO cpr pell 250 mg 90 pce
1 / 3
google

Details

Product number
6637401
CPT
-
Packaging group
90
Unit
Tablette(n)
Composition
ethylis telotristatas 250 mg ut telotristati etipras 327.9 mg corresp. telotristatum 237.80 mg, lactosum 167.91 mg, hydroxypropylcellulosum, carmellosum natricum conexum, natrium 4.54 mg, magnesii stearas, silica colloidalis, Überzug: poly(alcohol vinylicus), macrogolum 3350, talcum, E 171, pro compresso obducto.

Articles (1)

Xermelo 250 mg, Filmtabletten
Filmtabletten
90
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
11/04/2023
Patient information leaflet
Français
11/04/2023
Patient information leaflet
Italien
11/04/2023
Professional SmPC
Allemand
11/04/2023
Professional SmPC
Français
11/04/2023
Professional SmPC
Italien
11/04/2023

Detailed composition

Substance Quantity Type Category
(N/A)
250.0 MG Substance Wirkstoff (Principe actif)
(N/A)
327.9 MG Substance WIZUS
(N/A)
237.8 MG Substance WIZUS
(N/A)
167.91 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
4.54 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK

Authorization holder

Future Health Pharma GmbH

8620 Wetzikon ZH

Authorization information

Swissmedic authorization number
66374
Drug name
Xermelo, Filmtabletten
Galenic form
FILM
ATC Code
A16AX15
Authorization status
Z
Dispensation category
B
First authorization
28/03/2018
Authorization expiration date
31/12/9999
IT number
07.16.4.
Domain
Human medicine
Field of application
Karzinoid-Syndrom-bedingte Diarrhö

Packaging details

Description (FR)
XERMELO cpr pell 250 mg 90 pce
Description (DE)
XERMELO Filmtabl 250 mg 90 Stk
Market launch
28/03/2018
Narcotic (BTM)
No